David Alan Campbell - President and CEO, Director at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
JANX on Nasdaq
All Insider Reports
All Insider Reports

David Alan Campbell - trading volume in the past year for Janux Therapeutics, Inc.

Holdings reported by David Alan Campbell for Janux Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 381,582 $6,051,890 $15.86 02 Jan 2026 Direct
Stock option (right to buy) 338,100 02 Jan 2026 Direct Common Stock

Transactions reported by David Alan Campbell for Janux Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.